The role of pharmacogenomics in precision psychiatry DOI
Mirko Manchia, Martino Belvederi Murri

Pharmacogenomics, Год журнала: 2023, Номер 24(10), С. 523 - 527

Опубликована: Июль 1, 2023

The field of psychiatry is facing an important paradigm shift in the provision clinical care and mental health service organization toward personalization integration multimodal data science. This approach, termed precision psychiatry, aims at identifying subgroups patients more prone to development a certain phenotype, such as symptoms or severe disorders (risk detection), and/or guide treatment selection. Pharmacogenomics computational are two fundamental tools which have seen increasing levels settings. Here we present brief overview these applications

Язык: Английский

Digital Phenotyping: Data-Driven Psychiatry to Redefine Mental Health DOI Creative Commons
Antoine Oudin, Redwan Maatoug, Alexis Bourla

и другие.

Journal of Medical Internet Research, Год журнала: 2023, Номер 25, С. e44502 - e44502

Опубликована: Авг. 21, 2023

The term "digital phenotype" refers to the digital footprint left by patient-environment interactions. It has potential for both research and clinical applications but challenges our conception of health care opposing 2 distinct approaches medicine: one centered on illness with aim classifying curing disease, other patients, their personal distress, lived experiences. In context mental psychiatry, benefits phenotyping include creating new avenues treatment enabling patients take control own well-being. However, this comes at cost sacrificing fundamental human element psychotherapy, which is crucial addressing patients' distress. viewpoint paper, we discuss advances rendered possible highlight risk that technology may pose partially excluding professionals from diagnosis therapeutic process, thereby foregoing an essential dimension care. We conclude setting out concrete recommendations how improve current so it can be harnessed redefine empowering without alienating them.

Язык: Английский

Процитировано

36

A cultural-ecosocial systems view for psychiatry DOI Creative Commons
Ana Gómez-Carrillo, Laurence J. Kirmayer

Frontiers in Psychiatry, Год журнала: 2023, Номер 14

Опубликована: Апрель 13, 2023

While contemporary psychiatry seeks the mechanisms of mental disorders in neurobiology, health problems clearly depend on developmental processes learning and adaptation through ongoing interactions with social environment. Symptoms or emerge specific contexts involve predicaments that cannot be fully characterized terms brain function but require a larger social-ecological view. Causal result can begin anywhere within extended system body-person-environment. In particular, individuals' narrative self-construal, culturally mediated interpretations symptoms coping strategies as well responses others world contribute to disorders, illness experience, recovery. this paper, we outline conceptual basis practical implications hierarchical ecosocial systems view for an integrative approach psychiatric theory practice. The cultural-ecosocial propose understands mind, person situated constituted by cultural self-reflexive processes. This incorporated into pragmatic clinical assessment case formulation characterizes pathology identifies targets intervention.

Язык: Английский

Процитировано

28

Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine DOI
Nadia Μ. Hamdy, Emad B. Basalious,

Mona G. El-Sisi

и другие.

Current Medical Research and Opinion, Год журнала: 2024, Номер 40(11), С. 1943 - 1961

Опубликована: Окт. 16, 2024

The development of therapies followed a generalized approach for long time, assuming that single treatment could effectively address various patient populations. However, recent breakthroughs have revealed the limitations this one-size-fits-all paradigm. More recently, field therapeutics has witnessed shift toward other modules, including cell therapies, high molecular weight remedies, personalized medicines, and gene therapies. Such advancements in therapeutic modules potential to revolutionize healthcare pave way medicines are more efficient with minimal side effects. Cell gained considerable attention regenerative medicine. Stem cell-based instance, hold promise tissue repair regeneration, ongoing research focusing on enhancing their efficacy safety. High drugs like peptides proteins emerged as promising because specificity diverse biological functions. Engineered developed targeted drug delivery, immunotherapy, disease-modulation. In medicine, tailored treatments individuals based specific genetic profiling, lifestyle, biomarkers, disease characteristics all implemented. Clinicians optimize outcomes minimize adverse effects, using mutations, yielding remarkable results. Gene revolutionized disorders by directly targeting underlying abnormalities. Innovative techniques, such CRISPR-Cas9 allowed precise editing, opening up possibilities curing previously incurable conditions. conclusion,

Язык: Английский

Процитировано

10

The current clinical approach to feeding and eating disorders aimed to increase personalization of management DOI Open Access
Ulrike Schmidt, Angélica Medeiros Claudino, Fernando Fernández‐Aranda

и другие.

World Psychiatry, Год журнала: 2025, Номер 24(1), С. 4 - 31

Опубликована: Янв. 15, 2025

Feeding and eating disorders (FEDs) are a heterogeneous grouping of at the mind-body interface, with typical onset from childhood into emerging adulthood. They occur along spectrum disordered compensatory weight management behaviors, low to high body weight. Psychiatric comorbidities norm. In contrast other major psychiatric disorders, first-line treatments for FEDs mainly psychological and/or nutrition-focused, medications playing minor adjunctive role. Patients, carers clinicians all have identified personalization treatment as priority. Yet, FEDs, evidence base supporting this is limited. Importantly, related behaviors can serious physical consequences may put patient's life risk. these cases, immediate safety risk considerations least period need be prioritized over efforts care. This paper systematically reviews several key domains that relevant characterization individual patient FED aimed management. These include symptom profile, clinical subtypes, severity, staging, complications consequences, antecedent concomitant conditions, social functioning quality life, neurocognition, cognition emotion, dysfunctional cognitive schemata, personality traits, family history, early environmental exposures, recent stigma, protective factors. Where possible, validated assessment measures use in practice identified. The limitations current pointed out, possible directions future research highlighted. also novel approaches providing more fine-grained sophisticated ways personalize such those utilize neurobiological markers. We additionally outline remote measurement technologies designed delineate patients' illness recovery trajectories facilitate development intervention approaches.

Язык: Английский

Процитировано

1

The missing hallmark of health: psychosocial adaptation DOI
Carlos López‐Otín, Guido Kroemer

Cell Stress, Год журнала: 2024, Номер 8, С. 21 - 50

Опубликована: Янв. 1, 2024

The eight biological hallmarks of health that we initially postulated (Cell. 2021 Jan 7;184(1):33-63) include features spatial compartmentalization (integrity barriers, containment local perturbations), maintenance homeostasis over time (recycling & turnover, integration circuitries, rhythmic oscillations) and an array adequate responses to stress (homeostatic resilience, hormetic regulation, repair regeneration). These affect all somatic strata the human body (molecules, organelles, cells, supracellular units, organs, organ systems, systemic circuitries meta-organism). Here postulate mental socioeconomic factors must be added this 8×8 matrix as additional hallmark (“psychosocial adaptation”) stratum interactions”), hence building a 9×9 matrix. Potentially, perturbation each affects psychosocial vice versa. Finally, discuss (patho)physiological bases these interactions their implications for improvement.

Язык: Английский

Процитировано

6

Qualitative analytics from stakeholder perspective describes the biopsychosocial model for patient-centred approach to managing psychiatric ailments DOI Creative Commons
Abhishek Cukkemane,

Rene Hurlemann,

Veralia Gabriela Sánchez

и другие.

Journal of Affective Disorders Reports, Год журнала: 2025, Номер unknown, С. 100893 - 100893

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Unpacking “the social”: a cultural–ecosocial systems approach DOI
Laurence J. Kirmayer

Social Psychiatry and Psychiatric Epidemiology, Год журнала: 2024, Номер 59(3), С. 567 - 569

Опубликована: Янв. 23, 2024

Язык: Английский

Процитировано

4

Is sharing always caring? Entropy, boundaries and the plurality of psychotherapeutic process DOI

Lena Adel,

Ana Gómez-Carrillo,

Jonas Mago

и другие.

Physics of Life Reviews, Год журнала: 2025, Номер 52, С. 250 - 252

Опубликована: Янв. 16, 2025

Язык: Английский

Процитировано

0

The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment DOI
Georgios Schoretsanitis, Christoph U. Correll, Agorastos Agorastos

и другие.

The World Journal of Biological Psychiatry, Год журнала: 2024, Номер 25(6), С. 342 - 351

Опубликована: Июнь 21, 2024

Objectives This survey assessed psychiatry residents'/early-career psychiatrists' attitudes towards the utility of therapeutic drug monitoring (TDM) antipsychotics.

Язык: Английский

Процитировано

3

Insomnia symptoms and neurofunctional correlates among adults receiving buprenorphine for opioid use disorder DOI Creative Commons
Augustus M White,

Michelle Eglovitch,

Anna Beth Parlier‐Ahmad

и другие.

PLoS ONE, Год журнала: 2024, Номер 19(6), С. e0304461 - e0304461

Опубликована: Июнь 13, 2024

Insomnia symptoms are negatively related to opioid use disorder (OUD) treatment outcomes, possibly reflecting the influence of sleep on neurofunctional domains implicated in addiction. Moreover, intersection between OUD recovery and represents an area well-suited for development novel, personalized strategies. This study assessed prevalence clinically significant insomnia characterized its correlates among a clinical sample adults with receiving buprenorphine.

Язык: Английский

Процитировано

1